Department of Pathophysiology, Zhongshan School of Medicine, Sun Yat-sen University, 74 Zhongshan Road II, Guangzhou 510089, People's Republic of China.
Cancer Lett. 2010 Jun 28;292(2):149-52. doi: 10.1016/j.canlet.2009.11.018. Epub 2010 Jan 4.
Triptolide, a diterpenoid triepoxide, is the key biological component of Tripterygium wilfordii Hook. f. which was used in traditional Chinese medicine for centuries to treat inflammation and autoimmune diseases. Triptolide has shown potent activity in not only anti-inflammation and immune modulation, but also antiproliferative and proapoptotic activity in many different types of cancer cells. However, for a long time, the precise molecular target(s) of triptolide have remained elusive. Recently, several groups discovered that triptolide inhibited the activity of RNA polymerase. This review will focus on these breakthrough findings about the molecular target of triptolide and its implications for targeted-cancer therapeutics.
雷公藤红素是一种二萜三环氧,是雷公藤(Tripterygium wilfordii Hook. f.)的主要生物活性成分,在中国传统医学中已使用了数个世纪来治疗炎症和自身免疫性疾病。雷公藤红素不仅具有强大的抗炎和免疫调节活性,而且对许多不同类型的癌细胞还具有抗增殖和促凋亡活性。然而,长期以来,雷公藤红素的确切分子靶标一直难以捉摸。最近,有几个研究小组发现雷公藤红素抑制了 RNA 聚合酶的活性。本综述将重点介绍雷公藤红素分子靶标的这些突破性发现及其对靶向癌症治疗的意义。